Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis

被引:0
|
作者
Azza AbuDagga
Judith J Stephenson
An-Chen Fu
Winghan Jacqueline Kwong
Hiangkiat Tan
William S Weintraub
机构
[1] HealthCore,
[2] Inc.,undefined
[3] Daiichi Sankyo,undefined
[4] Inc.,undefined
[5] Christiana Care Health System,undefined
关键词
Non-valvular atrial fibrillation; Dabigatran; Warfarin; Oral anticoagulation; Healthcare;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Creatinine monitoring patterns in the setting of direct oral anticoagulant therapy for non-valvular atrial fibrillation
    Gruca, Martin M.
    Li, Yun
    Kong, Xiaowen
    DeCamillo, Deborah
    Kline-Rogers, Eva
    Ali, Mona A.
    Kaatz, Scott
    Dahu, Musa
    Froehlich, James B.
    Barnes, Geoffrey D.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (03) : 500 - 505
  • [22] Factors associated with discontinuing or not starting oral anticoagulant therapy in older hospitalized patients with non-valvular atrial fibrillation
    Diez-Manglano, Jesus
    Mostaza, Jose-Maria
    Pose, Antonio
    Formiga, Francesc
    Cepeda, Jose-Maria
    Gullon, Alejandra
    Camafort, Miguel
    Castiella, Jesus
    Rovira, Eduardo
    Jarauta, Estibaliz
    Suarez, Carmen
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (08) : 1219 - 1224
  • [23] Daily costs of hospitalization in non-valvular atrial fibrillation patients treated with anticoagulant therapy
    Dasta, Joseph F.
    Pilon, Dominic
    Mody, Samir H.
    Lopatto, Jessica
    Laliberte, Francois
    Germain, Guillaume
    Bookhart, Brahim K.
    Lefebvre, Patrick
    Nutescu, Edith A.
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (12) : 1041 - 1049
  • [24] Inappropriate Dosing of Oral Anticoagulants among Patients With Non-Valvular Atrial Fibrillation
    Shrestha, Sulena
    Baser, Onur
    Zhou, Xinxiang
    Kwong, W. J.
    STROKE, 2017, 48
  • [25] DIRECT ORAL ANTICOAGULANT THERAPY IN NONAGENARIANS PATIENTS WITH NON VALVULAR ATRIAL FIBRILLATION
    Bolognesi, M. G.
    Rossi, L.
    Maceda, D. Penela
    Pelizzoni, V.
    Pisati, M. S.
    Aschieri, D.
    Torretta, L.
    Villani, G.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E138 - E138
  • [26] COMPARATIVE EFFECTIVENESS AND SAFETY OF LOW DOSE OF ORAL ANTICOAGULANT IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Perreault, S.
    Cote, R.
    De Denus, S.
    Dorais, M.
    VALUE IN HEALTH, 2020, 23 : S488 - S488
  • [27] Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases
    Lip, Gregory Y. H.
    Keshishian, Allison
    Kang, Amiee
    Luo, Xuemei
    Atreja, Nipun
    Zhang, Yan
    Schuler, Patricia
    Jiang, Jenny
    Yuce, Huseyin
    Deitelzweig, Steven
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (01) : 33 - 46
  • [28] Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases
    Gregory Y. H. Lip
    Allison Keshishian
    Amiee Kang
    Xuemei Luo
    Nipun Atreja
    Yan Zhang
    Patricia Schuler
    Jenny Jiang
    Huseyin Yuce
    Steven Deitelzweig
    Journal of Thrombosis and Thrombolysis, 2022, 54 : 33 - 46
  • [29] ANTICOAGULANT-THERAPY IN RECURRENT CEREBRAL EMBOLISM - A RETROSPECTIVE STUDY IN NON-VALVULAR ATRIAL-FIBRILLATION
    YAMANOUCHI, H
    NAGURA, H
    OHKAWA, Y
    SAKURAI, Y
    KUZUHARA, S
    KURAMOTO, K
    SHIMADA, H
    TOYOKURA, Y
    JOURNAL OF NEUROLOGY, 1988, 235 (07) : 407 - 410
  • [30] DEMOGRAPHIC AND SOCIOECONOMIC CHARACTERISTICS THAT IMPACT SELECTION OF ORAL ANTICOAGULANTS AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS
    Keshishian, A.
    Du, J.
    Xie, L.
    Yuce, H.
    Baser, O.
    VALUE IN HEALTH, 2016, 19 (03) : A55 - A55